Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
about
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunctionBotulinum toxin injections for low-back pain and sciaticaBotulinum toxin for low-back painEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyBotulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersUltrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the LiteratureTreatment of Chronic Migraine with Focus on Botulinum NeurotoxinsDevelopment of onabotulinumtoxinA for chronic migrainePractice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headacheThe Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's diseaseTemporal characteristics of botulinum neurotoxin therapy.RimabotulinumtoxinB in sialorrhea: systematic review of clinical trialsSelective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains.Accelerated intoxication of GABAergic synapses by botulinum neurotoxin A disinhibits stem cell-derived neuron networks prior to network silencing.Subunit vaccine efficacy against Botulinum neurotoxin subtypes.Defining the differences between episodic migraine and chronic migraine.Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review.New drugs for migraineBotulinum toxin for the treatment of myofascial pain syndromes involving the neck and back: a review from a clinical perspectiveAssessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyUse of botulinum toxin type A in the management of patients with neurological disorders: a national surveyEmbryonic Stem Cell-Derived Neurons Grown on Multi-Electrode Arrays as a Novel In vitro Bioassay for the Detection of Clostridium botulinum Neurotoxins.Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management.Management of chronic daily headache in children.The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis.Poststroke hypertonicity: upper limb assessment and treatment.Treatment of refractory pain with botulinum toxins--an evidence-based review.Targeted secretion inhibitors-innovative protein therapeuticsOnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.Emerging treatment for chronic migraine and refractory chronic migraine.Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.Considerations in the treatment of tension-type headache in the elderly.Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.An update on the use of botulinum toxin therapy in Parkinson's disease.Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.Botulinum toxin: State of the art.Outcome of Chronic Daily Headache or Chronic Migraine.Chronic Daily Headache: Mechanisms and Principles of Management.
P2860
Q24194577-60B5E26F-D48C-4AB9-BAD4-F59080CD1DAEQ24234725-4A7440A2-B766-46A9-B8EE-EDF6E6BB1E8DQ24241281-518A59B6-14DF-494E-AEC2-A53D0130E5C2Q24633523-4C43115F-2238-4B49-BBCA-F9513B202AC5Q26781281-EC669FAF-7DDF-4952-8035-4BDFC91AEE2BQ26798457-C5BEDD4E-D554-4BAE-8486-2FE91CBA963CQ26799906-A75AE124-929B-4009-861E-42BED1D48167Q27027006-768B5E4B-ADF5-47F0-A854-68D1004A478FQ29392461-088943BA-DDE0-4467-8866-1880C40BD183Q33607256-B3185C86-A67F-4A9F-BD70-6A2207191875Q33740588-8609D4C4-E84D-4C62-BFCA-ACEE17069783Q33768467-5C685CC4-8E97-49F6-8CF2-754257F78E6AQ34207258-D6E4DD01-389A-4003-8256-3536649137E9Q35531292-F72E4C30-C9F1-4CCD-A160-A1784B9C4674Q35532054-751198CD-6747-4080-BDF3-30F68AAE083AQ35672977-5ADC12B2-885A-404E-AD00-1C522DAB96E6Q35681903-171E7301-782A-4314-A6D1-9D7EAADC197CQ36091433-7F11156B-29C2-42A5-9F3E-7BDDDAAEE735Q36332611-D3C3BF74-51E5-4116-8B9B-8A90ED459374Q36663947-128A3D28-4C25-495A-8EC8-CA01B5A55F9BQ37155202-DF467B44-256D-4EF4-8480-EB8AE5FD2DDAQ37632889-48DC17AF-E457-4364-9028-58741B174BC6Q37660850-729C814E-61BF-47C1-854D-ED2D0A59CDA3Q37768289-7D63024C-AC12-4FFF-B224-2029FB3A3F62Q37785558-F78DAFC8-33F9-44E7-ABC9-2793093F25A5Q37809485-866E4511-1F1F-4169-99B7-F4F959073BF3Q37885037-BDC332BB-967B-436C-B694-C632E7785434Q37940623-FF07C00D-1637-4499-88A8-EE374F5D82DFQ37954277-F8287466-7182-4BC6-B627-A5B9BC0D4A3CQ37999053-14939D4F-03F7-412F-9931-D990C6B605BEQ38031982-9B9E7ACD-9B65-4765-9023-516ABFB3D914Q38080776-288E431E-5084-40A0-ADDD-6E9EB647DE64Q38260189-78C7486D-64F8-4221-A169-050B57280D3BQ38262923-B82EBC7E-500A-4BEC-BB58-ED56EED2E671Q38269292-34571045-E7CF-497C-BA65-4B3508812C67Q38406085-358FA0E8-CAF5-40A6-B215-C216F9DCA30CQ38642797-C53C0D2D-3872-4B64-9FC4-98C27C8B70CFQ38668149-23DEE77D-909D-4EA3-B1DB-1C0456C3560AQ38676484-A0565D9A-1E87-4DDD-ACC9-8215CEBA2BD1Q38700966-22A0811F-49C6-40BC-A7C9-3127BAD83908
P2860
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@ast
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@en
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain
@nl
type
label
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@ast
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@en
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain
@nl
prefLabel
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@ast
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@en
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain
@nl
P2093
P1433
P1476
Assessment: Botulinum neurotox ...... American Academy of Neurology.
@en
P2093
C E Argoff
D D Dykstra
D M Simpson
G S Gronseth
H C Kaufmann
M K Childers
S D Silberstein
P304
P356
10.1212/01.WNL.0000311390.87642.D8
P407
P577
2008-05-01T00:00:00Z